No insider purchase over the last 90 days. The latest, by SAUNDERS BRENT L, was filed 13 Aug 2024.
This page follows insider dealings at SkinHealth Systems Inc. as filed with SEC (Form 4), a company from the Food & Beverage sector. Over the twelve months to 23 October 2026, 14 filings were filed, from 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (3,167 companies, median 24 filings), a count of 14 filings is below the norm. Since 2021, the database holds 8 purchases and 1 sale by insiders of the company. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 300.8 m USD and net income at -9.5 m USD.
There has been no open-market purchase by an insider of SkinHealth Systems Inc. for at least a year. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate SkinHealth Systems Inc. Hold (neutral), based on 6 analysts. Average price target: US$17.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 128 declarations
SkinHealth Systems Inc. is a company focused on developing skin health solutions. It is listed on the XNAS market.
Insider filings
Over the last 90 days, 3 filings published between 12 August and 13 October 2026: no open-market purchase or sale filed by an insider. 3 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Recent news
From Investing.com France on 28 September 2026: "Les actionnaires de SkinHealth Systems approuvent le regroupement d’actions et l’ajournement" (headline in French).
Headlines quoted as published, with source and date. The gap to insider purchases is computed from the filings and implies no link between the article and the purchase. Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 300.8 m USD | -9.5 m USD | -0.16 USD | 10-K |
| Dec 2024 | 334.3 m USD | -29.1 m USD | -0.36 USD | 10-K |
| Dec 2023 | 398.0 m USD | -100.1 m USD | -0.76 USD | 10-K |
| Dec 2022 | 365.9 m USD | 44.2 m USD | -0.23 USD | 10-K |
| Dec 2021 | 260.1 m USD | -378.8 m USD | -3.71 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.